Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Impact of Breast Reconstruction on Weight Change

Plast Reconstr Surg; 2017 Dec; Cho, Shammas, et al

Women who underwent autologous breast reconstruction did not gain as much weight postdiagnosis as those who did not receive reconstruction, according to a propensity-match analysis involving 160 individuals. Participants included women who underwent mastectomy at a single institution between 2008 and 2010 (n=80), and those in a matched cohort who did not receive reconstruction (n=80). Investigators looked at the impact of overall body mass index (BMI) change, as well as change >5%, 1 to 4 years post-diagnosis. Among the results:

  • Women undergoing immediate reconstruction had reduced BMI changes 1, 2, and 3 years after diagnosis, vs those who did not have reconstruction.
  • After that time, reconstruction was predictive of reduced BMI changes.
  • Higher BMI increases were seen in 1) women who were leaner at diagnosis, and 2) those who received chemotherapy.
  • Normal baseline BMI and chemotherapy predicted greater BMI increases.

The authors noted that their findings can help clinicians select weight management strategies for high-risk patients.

Citation:

Cho E, Shammas R, Glener A, Greenup R, Hwang E, Hollenbeck S. The impact of autologous breast reconstruction on body mass index patterns in breast cancer patients: A propensity-matched analysis. Plast Reconstr Surg. 2017;140(6):1121-1131. doi:10.1097/PRS.0000000000003841.

This Week's Must Reads

Does Integrated Delivery Treatment Impact Cost? , J Oncol Pract; ePub 2018 Feb 13; Kaye, Min, et al

Anticancer Agent Dose Rounding Cost Impact Assessed, J Oncol Pract; ePub 2018 Feb 5; Fahrenbruch, et al

Employment in Patients with Early-Stage BC Studied , Cancer; ePub 2018 Feb 13; Ekenga, Pérez, et al

Program’s Impact on CRC Screening in Uninsured , Cancer; ePub 2018 Feb 7; Eberth, Thibault, et al

Charting the Landscape of Oncology Pathway Vendors , J Oncol Pract; ePub 2018 Feb 7; Daly, Zon, et al

Must Reads in Breast Cancer

FDA Approves Lynparza for Certain Types of BC, FDA news release; 2018 Jan 12

Stereotactic Radiotherapy System Approved For BC, FDA news release; 2017 Dec 22

Perjeta Approved for Certain Type of Early BC, Genentech news release; 2017 Dec 20

Do Women with BC Use Their Pain Meds Correctly?, J Pain Symptom Manage; ePub 2017 Dec 5; Stephenson, et al

Immediate Breast Reconstruction Likelihood Studied, Clin Breast Cancer; ePub 2017 Dec 6; Reddy, et al